Head of Marketing

USA (On-site)

Salary Not AvailableSenior Level10+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive growth and brand building in genetic medicine markets by leading data-driven marketing strategy and demand generation.

  • Must-have: 10+ years of senior marketing leadership and Go-to-Market execution with Sales partners
  • Standout: Experience using HubSpot/Salesforce for campaign tracking and lead nurturing

Job Description

Responsibilities

  • Develop and execute a comprehensive, data-driven marketing strategy to drive growth and brand awareness in conjunction with commercial stakeholders
  • Lead the marketing strategy , from demand generation to content marketing, and campaign management
  • Drive lead generation and conversion through innovative digital marketing strategies , including SEO, SEM, email campaigns, webinars, and social media marketing
  • Define and monitor key performance metrics (KPIs) to ensure the marketing team is meeting goals and objectives
  • Utilize marketing automation tools and CRM systems (e.g., HubSpot, Salesforce) to track, analyze, and optimize campaigns and lead nurturing efforts
  • Use data and analytics to measure campaign performance, generate insights, and continuously improve marketing ROI
  • Manage and optimize the lead funnel to convert leads into qualified opportunities and customers, working closely with the Sales team to ensure smooth handoffs and a seamless sales process
  • Build, mentor, and lead a high-performing marketing team , fostering a culture of collaboration, creativity, and data-driven decision making
  • Recruit, retain, and develop top-tier marketing talent , ensuring team members have the necessary skills and resources to succeed.
  • Responsibilities include developing plans to help establish our brand , allocating resources to different projects and setting short-term and long-term department goals . Ultimately, you will run our Marketing department to drive demand and consequently marketing generated revenue.

Requirements

  • A proven recent track record of marketing success in the Genetic Medicine market, DNA Services, Biologics, Business Development (or related) industry
  • 10+ years senior marketing leadership experience successfully executing Go to Marketing Strategies in conjunction with Sales Partners
  • Experience of setting up successful marketing processes in line with commercial strategy
  • A detailed understanding of CDMO services, production and manufacturing processes and regulations
  • Exceptional creative and presentation skills
  • Strong analytics and forecasting experience
  • A self-starter , with a desire to meet targets and drive success
  • Innovative, pragmatic, team-focused and customer-oriented personality
  • BA/BSc or equivalent educational background ground.

Benefits

  • Touchlight is a successful scale-up business with a record of world-leading innovation and a welcoming, entrepreneurial culture. We make Touchlight an extraordinary place to work by providing our employees with incredible facilities, flexible working and a competitive benefits and remuneration package.
  • A Place for Everyone
  • We believe diversity drives innovation and for that reason we strongly encourage those from all backgrounds to apply for roles at Touchlight. We are an equal opportunity employer and aim to build a workforce that is truly representative of the communities in which we operate and our customers.
  • If you need reasonable adjustments at any point in the application or interview process, please speak with the HR team who will be happy to support you.
Touchlight logo

Touchlight

3.5 Glassdoor

Touchlight is an innovation-driven, leading CDMO pioneering enzymatic DNA production to enable the genetic medicine revolution. As pioneers with an FDA Drug Master Filing already accepted in 2022, our enzymatic DNA technology is on the cutting edge of AAV, mRNA, DNA vaccine, and in vivo gene editing innovation. With multiple client products already in the clinic, our evidence-based, data-supported synthetic DNA manufacturing solutions offer a scalable, sustainable alternative to plasmid DNA (pDNA) for all stages of pre-clinical, clinical and commercial development. Our company and technology are built on the conviction that DNA is fundamental to the future of medicine. Traditional methods, based on bacterial fermentation, are slow, costly, and unable to meet the growing demands of genetic medicine due to limited scalability and speed. Founded in 2007, our team is inspired by breakthroughs in genome sequencing, recognizing the urgent need for innovative DNA production techniques to support the future of genetic therapies. To address these challenges, we developed our first novel synthetic DNA vector, dbDNATM, alongside a proprietary enzymatic manufacturing process. This groundbreaking approach enables the production of complex DNA sequences with remarkable speed, scale, and purity, surpassing the limitations of traditional pDNA production while transforming the economics of bringing these therapies to market more efficiently and sustainably. Touchlight’s commitment to innovation is continually fueling product improvements and new product development. As of early 2024, we have partnered with hundreds of biotech and top 10 pharmaceutical companies, producing synthetic DNA for use as both a starting material and an active pharmaceutical ingredient. By the end of this year, dbDNATM will be one of multiple synthetic DNA products in our portfolio that will continue to pave the way for more accessible cell and gene therapies.

Founded in 2008
Hampton, England, GBR
193 employees (6 in marketing)
58% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
9K
Traffic Source Mix
Search
30.8%
Direct
24.1%
Referral
4.8%
Social
4.4%
Paid
0.6%

Headcount Trend

Current headcount: ~193

Marketing Team

Marketing Team Size
6 (3% of company)

Funding

Total Funding
$130.4M
Last Raise
$2.4M
Grant, 3 years ago

Funding History

  • Nov 2022
    Grant • $2.4M
  • Sep 2021
    Series Unknown • $69.2M
  • Mar 2021
    Series Unknown • $58.7M